Q-omics provides the consensus-scored RN7SL724P profile across patient tissues and cancer cell-line models. RN7SL724P expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, RN7SL724P is differentially expressed in 8, with the highest sampling consensus in THCA. Additionally, RN7SL724P RNA expression shows 12,069 significant gene co-expression associations, with the highest sampling consensus in KIRP. Together, these results highlight UCEC, THCA, and KIRP as cancer lineages where RN7SL724P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RN7SL724P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RN7SL724P survival associations across molecular data types. RN7SL724P RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RN7SL724P RNA expression–survival associations across cancer types. High RN7SL724P expression shows unfavorable associations in UCEC, READ and LUAD, but favorable associations in LGG, PAAD and SKCM. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .003). Together, the overview and detailed table identify UCEC as the clearest survival context for RN7SL724P RNA expression.
This table summarizes RN7SL724P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for RN7SL724P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RN7SL724P shows lower tumor expression in THCA, KICH and UCEC and higher tumor expression in LUSC, COAD and CHOL. The THCA box plot shows higher RN7SL724P RNA expression in normal versus tumor tissue (log2 FC = −0.239, t-test p < 0.001).
This table shows molecular features associated with RN7SL724P in patient tissues and cancer cell lines. In patient samples, RN7SL724P shows the broadest associations at the RNA and protein expression levels, with KIRP recurring as the lineage with the largest associated feature set.
